Posted by Michael Wonder on 06 Feb 2024
Updates on NICE and SMC collaboration on MTA for cystic fibrosis
1 February 2024 - On 19 December 2023, we advised that NICE would be liaising with key stakeholders to determine the most appropriate next steps.
Since then, work has continued to ensure that the MTA committee outputs are clear for all parties who would be involved in any formal commercial negotiation. This initial phase is now complete. The next phase will be commercial negotiations.
